scholarly journals A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

Drugs & Aging ◽  
2016 ◽  
Vol 34 (1) ◽  
pp. 29-38 ◽  
Author(s):  
Tim Heise ◽  
Ulrike Hövelmann ◽  
Eric Zijlstra ◽  
Kirstine Stender-Petersen ◽  
Jacob Bonde Jacobsen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Insulin Aspart ◽  
Elderly Subjects ◽  
Acting Insulin

scholarly journals Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus

2016 ◽  
Vol 56 (6) ◽  
pp. 649-660 ◽  
Author(s):  
Tim Heise ◽  
Kirstine Stender-Petersen ◽  
Ulrike Hövelmann ◽  
Jacob Bonde Jacobsen ◽  
Leszek Nosek ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Insulin Aspart ◽  
Dose Range ◽  
Acting Insulin ◽  
Relevant Dose

scholarly journals Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus

2017 ◽  
Vol 18 (8) ◽  
pp. 903-910 ◽  
Author(s):  
Maryam Fath ◽  
Thomas Danne ◽  
Torben Biester ◽  
Lars Erichsen ◽  
Olga Kordonouri ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Children And Adolescents ◽  
Insulin Aspart ◽  
Early Exposure ◽  
Acting Insulin
Sign in / Sign up

Export Citation Format

Share Document